Volume Alert - AKRX 37.88 Akorn Inc $AKRX Hit a hi
Post# of 77
Posted On: 11/07/2014 12:48:40 AM
Volume Alert - AKRX 37.88 Akorn Inc $AKRX Hit a high today of 42.49 Closing the day 11/06/14 at 37.88 -3.80 -9.12% With a day low of 36.35 and a total volume of 6,982,935.
AKRX Recent Posts: http://investorshangout.com/Akorn-AKRX-53272/
AKRX Akorn Inc Recent Headline News
A/D Rating Helps Spot What The Pros Are Buying
at Investor's Business Daily - Thu Nov 06, 5:41PM CST
If you're prepping a small patch of land, a shovel and a hoe from Home Depot (HD) will suffice. But if you have acres to dig up, then you'll need industrial-size earth-moving equipment. In the stock market, it takes big money from professional...
BCC: 37.60 (+1.02), HD: 97.29 (+1.51), AKRX: 37.88 (-3.80), ILMN: 189.87 (+3.50)
SmarTrend Watching for Potential Rebound in Shares of Akorn After 9.12% Loss
Comtex SmarTrend(R) - Thu Nov 06, 4:05PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $36.35 to a high of $42.49. Yesterday, the shares fell 9.1%, which took the trading range below the 3-day low of $41.17 on volume of 6.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 37.88 (-3.80)
Stocks Gain On Draghi Comments, Economic Data
at Investor's Business Daily - Thu Nov 06, 3:25PM CST
Stocks scored modest gains Thursday, thanks in part to ECB President Mario Draghi's pledge for stimulus and better-than-expected domestic data on jobless claims and productivity. The Dow Jones industrial average and the S&P 500 rose 0.4% each. Both...
GPRO: 78.76 (+2.87), SWIR: 33.60 (+7.06), AAP: 145.56 (-3.81), AKRX: 37.88 (-3.80), BABA: 111.57 (+2.90)
Akorn (AKRX) Stock Lower Today After Reporting Third Quarter Earnings Results
at The Street - Thu Nov 06, 2:50PM CST
Shares of Akorn (AKRX) are down after reporting 2014 third quarter earnings that revealed $39.9 million in costs related to price increases.
AKRX: 37.88 (-3.80)
Stocks Up Slightly After Choppy Action
at Investor's Business Daily - Thu Nov 06, 12:26PM CST
Stocks were modestly higher after struggling for direction earlier. Overall, equities have wavered Thursday amid news of potential stimulus by the European Central Bank and better-than-expected data on jobless claims and productivity. The Dow Jones...
GPRO: 78.76 (+2.87), SWIR: 33.60 (+7.06), AKRX: 37.88 (-3.80), FRGI: 55.48 (-2.52), BABA: 111.57 (+2.90)
Video: Akorn Reports 'Messy' Quarter, Slamming Stock
at Investor's Business Daily - Thu Nov 06, 12:19PM CST
Generic-drug maker and IBD 50 stock Akorn (AKRX) on Thursday reported Q3 results complicated by accounting issues, sending the stock down nearly 11% in afternoon trade on the stock market today . The company's revenue totaled $132.7 million, up 62%...
AKRX: 37.88 (-3.80)
Stocks Down As Early Gains Fade; Generac Dives, Tableau Soars
at Investor's Business Daily - Thu Nov 06, 9:41AM CST
Stocks twisted opening gains into thin losses Thursday, as economic news and company reports fed the bulk of early action. The S&P 500 dipped 0.2%. The Nasdaq hovered a fraction into the red and the Dow Jones industrial average held effectively flat....
WFM: 44.85 (+4.86), TSLA: 241.22 (+10.25), AAP: 145.56 (-3.81), AKRX: 37.88 (-3.80), SLXP: 138.55 (-0.95), DIS: 92.00 (+1.00), GNW: 8.66 (-5.41), CDW: 32.48 (+1.15), NVDA: 20.22 (+0.09), QCOM: 70.58 (-6.62), GNRC: 42.09 (-1.43), LOCO: 37.30 (+0.95), DATA: 84.29 (+7.79)
Akorn reports 3Q loss
Automated Insights - Thu Nov 06, 6:51AM CST
LAKE FOREST, Ill. (AP) _ Akorn Inc. (AKRX) on Thursday reported a loss of $11.7 million in its third quarter.
AKRX: 37.88 (-3.80)
Akorn Reports Preliminary 2014 Third Quarter Results
GlobeNewswire - Thu Nov 06, 6:30AM CST
Akorn, Inc. (Nasdaq:AKRX), a niche pharmaceutical company, today reported preliminary financial results for the fiscal third quarter ended September 30, 2014.
AKRX: 37.88 (-3.80)
Video: 3 IBD 50 Tech, Drug Stocks With Earnings Thursday
at Investor's Business Daily - Wed Nov 05, 7:01PM CST
Several IBD 50 drug and tech companies release quarterly earnings results on Thursday: Akorn, Salix Pharmaceuticals and Skyworks Solutions. All three have IBD's highest possible Composite Rating, a 99, meaning their shares outperform 99% of all...
AGN: 197.40 (+1.08), ACT: 250.38 (+2.47), SWKS: 62.14 (+1.26), AKRX: 37.88 (-3.80), SLXP: 138.55 (-0.95), AAPL: 108.70 (-0.16)
Let Major Indexes Dictate Buy, Sell Decisions
at Investor's Business Daily - Wed Nov 05, 5:01PM CST
The S&P 500 and Nasdaq composite serve as guideposts to the market's health. Ignore them at your own peril. Every day, IBD analyzes the action of these major stock averages to determine whether the market is in an uptrend (healthy) or a correction...
LCI: 50.99 (-2.16), AKRX: 37.88 (-3.80), ORLY: 179.61 (+2.15), AFSI: 50.47 (-1.02), CELG: 107.14 (+1.99)
Stocks End Mildy Mixed, But Leading Growth Names Hit Hard
at Investor's Business Daily - Wed Nov 05, 3:35PM CST
Major averages ended mixed Wednesday. The Nasdaq lagged, but not by much, weighed down by weakness in 3D printing, solar, security and online travel stocks. At the close, the Dow Jones industrial average and S&P 500 scored new closing highs, rising...
MNST: 100.48 (+1.31), CAVM: 52.29 (+0.04), TSLA: 241.22 (+10.25), SWIR: 33.60 (+7.06), SWKS: 62.14 (+1.26), AKRX: 37.88 (-3.80), NXPI: 73.47 (+0.11), HAIN: 107.84 (+2.18), SCTY: 51.54 (-2.90), QCOM: 70.58 (-6.62), AVGO: 87.63 (+0.92), PAYC: 21.59 (+0.44)
Akorn Carves Out Rare Short-Stroke Pattern
at Investor's Business Daily - Tue Nov 04, 5:09PM CST
Many stocks featured in the Stock Spotlight are extended from recent base breakouts. These stocks can be frustrating for growth investors looking to deploy capital, but should an investor ignore them? Not if the charts shape a follow-on entry....
AKRX: 37.88 (-3.80)
Uptrend Call Working As Akorn Stock Rises 13.0% (AKRX)
Comtex SmarTrend(R) - Tue Nov 04, 9:22AM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on October 20th, 2014 at $38.26. In approximately 2 weeks, Akorn has returned 13.00% as of today's recent price of $43.23.
AKRX: 37.88 (-3.80)
Salix, Skyworks Lead 6 IBD50 EarningsReports On Tap
at Investor's Business Daily - Tue Nov 04, 7:02AM CST
Earnings season continues to barrel forward, and investors are anticipating results from several top drugmakers this upcoming week. This week's IBD 50, a roundup of top-rated growth stocks with solid fundamentals, boasts six companies reporting...
DRTX: 24.10 (+0.10), AGN: 197.40 (+1.08), ACT: 250.38 (+2.47), SWKS: 62.14 (+1.26), AKRX: 37.88 (-3.80), JAZZ: 172.37 (+5.19), SLXP: 138.55 (-0.95), AAPL: 108.70 (-0.16), ATHM: 45.23 (+1.15)
Technical Coverage of Pharma Stocks - Repros Therapeutics, Nektar Therapeutics, Akorn, AcelRx Pharma, and Pernix Therapeutics Holdings
PR Newswire - Mon Nov 03, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Repros Therapeutics Inc. (NASDAQ: RPRX), Nektar Therapeutics (NASDAQ: NKTR), Akorn Inc. (NASDAQ: AKRX), AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX), and Pernix Therapeutics Holdings Inc. (NASDAQ: PTX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, October 31, 2014, the NASDAQ Composite ended at 4,630.74, up 1.41%, the Dow Jones Industrial Average advanced 1.13%, to finish the day at 17,390.52, and the S&P 500 closed at 2,018.05, up 1.17%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 778.85, up 0.51%, with the index also advancing 10.60% in the previous three months. Register for your complimentary reports on these five stocks at:
ACRX: 5.63 (-0.58), PTX: 9.26 (-0.05), AKRX: 37.88 (-3.80), RPRX: 6.45 (+0.03), NKTR: 13.56 (-0.04)
IBD 50 Caps Impressive 2-Week Rally
at Investor's Business Daily - Fri Oct 31, 5:47PM CDT
The IBD 50 just capped its best two-week performance in more than three years -- a run that's produced a batch of breakouts. The index rallied 9.4% over the past two weeks. That's the best two-week period since July 2011, when the IBD 50 roared...
ODFL: 75.25 (+1.04), AAP: 145.56 (-3.81), AKRX: 37.88 (-3.80), ILMN: 189.87 (+3.50), NXPI: 73.47 (+0.11), CDW: 32.48 (+1.15), CELG: 107.14 (+1.99), BIDU: 236.90 (-0.80), GILD: 106.94 (+0.89), JAZZ: 172.37 (+5.19), FLT: 150.47 (+1.96), FL: 54.47 (+1.76), AAPL: 108.70 (-0.16), AVGO: 87.63 (+0.92)
Lannett Co. Gets Growth Rx In Generic Drugs Group
at Investor's Business Daily - Mon Oct 27, 4:59PM CDT
Generic-drug maker Lannett Co. boasts a robust pipeline and has its sights on growing revenue substantially over the next several years. The Philadelphia-based company is already on solid footing. In late August, it reported fiscal 2014...
LCI: 50.99 (-2.16), PRGO: 152.49 (-6.01), ACT: 250.38 (+2.47), AKRX: 37.88 (-3.80), TEVA: 58.72 (+0.93)
IBD 50 Stocks Regain Buy Points
at Investor's Business Daily - Fri Oct 24, 5:54PM CDT
The IBD 50 has been the land of the second chance, as many stocks have rebounded from sell signals. In several cases, stocks triggered the 8% sell rule or hit another sell signal. Yet a lot of them have rallied back and reclaimed their buy points....
AKRX: 37.88 (-3.80), ALXN: 193.14 (+3.25), CELG: 107.14 (+1.99)
AKRX Recent Posts: http://investorshangout.com/Akorn-AKRX-53272/
AKRX Akorn Inc Recent Headline News
A/D Rating Helps Spot What The Pros Are Buying
at Investor's Business Daily - Thu Nov 06, 5:41PM CST
If you're prepping a small patch of land, a shovel and a hoe from Home Depot (HD) will suffice. But if you have acres to dig up, then you'll need industrial-size earth-moving equipment. In the stock market, it takes big money from professional...
BCC: 37.60 (+1.02), HD: 97.29 (+1.51), AKRX: 37.88 (-3.80), ILMN: 189.87 (+3.50)
SmarTrend Watching for Potential Rebound in Shares of Akorn After 9.12% Loss
Comtex SmarTrend(R) - Thu Nov 06, 4:05PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $36.35 to a high of $42.49. Yesterday, the shares fell 9.1%, which took the trading range below the 3-day low of $41.17 on volume of 6.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 37.88 (-3.80)
Stocks Gain On Draghi Comments, Economic Data
at Investor's Business Daily - Thu Nov 06, 3:25PM CST
Stocks scored modest gains Thursday, thanks in part to ECB President Mario Draghi's pledge for stimulus and better-than-expected domestic data on jobless claims and productivity. The Dow Jones industrial average and the S&P 500 rose 0.4% each. Both...
GPRO: 78.76 (+2.87), SWIR: 33.60 (+7.06), AAP: 145.56 (-3.81), AKRX: 37.88 (-3.80), BABA: 111.57 (+2.90)
Akorn (AKRX) Stock Lower Today After Reporting Third Quarter Earnings Results
at The Street - Thu Nov 06, 2:50PM CST
Shares of Akorn (AKRX) are down after reporting 2014 third quarter earnings that revealed $39.9 million in costs related to price increases.
AKRX: 37.88 (-3.80)
Stocks Up Slightly After Choppy Action
at Investor's Business Daily - Thu Nov 06, 12:26PM CST
Stocks were modestly higher after struggling for direction earlier. Overall, equities have wavered Thursday amid news of potential stimulus by the European Central Bank and better-than-expected data on jobless claims and productivity. The Dow Jones...
GPRO: 78.76 (+2.87), SWIR: 33.60 (+7.06), AKRX: 37.88 (-3.80), FRGI: 55.48 (-2.52), BABA: 111.57 (+2.90)
Video: Akorn Reports 'Messy' Quarter, Slamming Stock
at Investor's Business Daily - Thu Nov 06, 12:19PM CST
Generic-drug maker and IBD 50 stock Akorn (AKRX) on Thursday reported Q3 results complicated by accounting issues, sending the stock down nearly 11% in afternoon trade on the stock market today . The company's revenue totaled $132.7 million, up 62%...
AKRX: 37.88 (-3.80)
Stocks Down As Early Gains Fade; Generac Dives, Tableau Soars
at Investor's Business Daily - Thu Nov 06, 9:41AM CST
Stocks twisted opening gains into thin losses Thursday, as economic news and company reports fed the bulk of early action. The S&P 500 dipped 0.2%. The Nasdaq hovered a fraction into the red and the Dow Jones industrial average held effectively flat....
WFM: 44.85 (+4.86), TSLA: 241.22 (+10.25), AAP: 145.56 (-3.81), AKRX: 37.88 (-3.80), SLXP: 138.55 (-0.95), DIS: 92.00 (+1.00), GNW: 8.66 (-5.41), CDW: 32.48 (+1.15), NVDA: 20.22 (+0.09), QCOM: 70.58 (-6.62), GNRC: 42.09 (-1.43), LOCO: 37.30 (+0.95), DATA: 84.29 (+7.79)
Akorn reports 3Q loss
Automated Insights - Thu Nov 06, 6:51AM CST
LAKE FOREST, Ill. (AP) _ Akorn Inc. (AKRX) on Thursday reported a loss of $11.7 million in its third quarter.
AKRX: 37.88 (-3.80)
Akorn Reports Preliminary 2014 Third Quarter Results
GlobeNewswire - Thu Nov 06, 6:30AM CST
Akorn, Inc. (Nasdaq:AKRX), a niche pharmaceutical company, today reported preliminary financial results for the fiscal third quarter ended September 30, 2014.
AKRX: 37.88 (-3.80)
Video: 3 IBD 50 Tech, Drug Stocks With Earnings Thursday
at Investor's Business Daily - Wed Nov 05, 7:01PM CST
Several IBD 50 drug and tech companies release quarterly earnings results on Thursday: Akorn, Salix Pharmaceuticals and Skyworks Solutions. All three have IBD's highest possible Composite Rating, a 99, meaning their shares outperform 99% of all...
AGN: 197.40 (+1.08), ACT: 250.38 (+2.47), SWKS: 62.14 (+1.26), AKRX: 37.88 (-3.80), SLXP: 138.55 (-0.95), AAPL: 108.70 (-0.16)
Let Major Indexes Dictate Buy, Sell Decisions
at Investor's Business Daily - Wed Nov 05, 5:01PM CST
The S&P 500 and Nasdaq composite serve as guideposts to the market's health. Ignore them at your own peril. Every day, IBD analyzes the action of these major stock averages to determine whether the market is in an uptrend (healthy) or a correction...
LCI: 50.99 (-2.16), AKRX: 37.88 (-3.80), ORLY: 179.61 (+2.15), AFSI: 50.47 (-1.02), CELG: 107.14 (+1.99)
Stocks End Mildy Mixed, But Leading Growth Names Hit Hard
at Investor's Business Daily - Wed Nov 05, 3:35PM CST
Major averages ended mixed Wednesday. The Nasdaq lagged, but not by much, weighed down by weakness in 3D printing, solar, security and online travel stocks. At the close, the Dow Jones industrial average and S&P 500 scored new closing highs, rising...
MNST: 100.48 (+1.31), CAVM: 52.29 (+0.04), TSLA: 241.22 (+10.25), SWIR: 33.60 (+7.06), SWKS: 62.14 (+1.26), AKRX: 37.88 (-3.80), NXPI: 73.47 (+0.11), HAIN: 107.84 (+2.18), SCTY: 51.54 (-2.90), QCOM: 70.58 (-6.62), AVGO: 87.63 (+0.92), PAYC: 21.59 (+0.44)
Akorn Carves Out Rare Short-Stroke Pattern
at Investor's Business Daily - Tue Nov 04, 5:09PM CST
Many stocks featured in the Stock Spotlight are extended from recent base breakouts. These stocks can be frustrating for growth investors looking to deploy capital, but should an investor ignore them? Not if the charts shape a follow-on entry....
AKRX: 37.88 (-3.80)
Uptrend Call Working As Akorn Stock Rises 13.0% (AKRX)
Comtex SmarTrend(R) - Tue Nov 04, 9:22AM CST
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on October 20th, 2014 at $38.26. In approximately 2 weeks, Akorn has returned 13.00% as of today's recent price of $43.23.
AKRX: 37.88 (-3.80)
Salix, Skyworks Lead 6 IBD50 EarningsReports On Tap
at Investor's Business Daily - Tue Nov 04, 7:02AM CST
Earnings season continues to barrel forward, and investors are anticipating results from several top drugmakers this upcoming week. This week's IBD 50, a roundup of top-rated growth stocks with solid fundamentals, boasts six companies reporting...
DRTX: 24.10 (+0.10), AGN: 197.40 (+1.08), ACT: 250.38 (+2.47), SWKS: 62.14 (+1.26), AKRX: 37.88 (-3.80), JAZZ: 172.37 (+5.19), SLXP: 138.55 (-0.95), AAPL: 108.70 (-0.16), ATHM: 45.23 (+1.15)
Technical Coverage of Pharma Stocks - Repros Therapeutics, Nektar Therapeutics, Akorn, AcelRx Pharma, and Pernix Therapeutics Holdings
PR Newswire - Mon Nov 03, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Repros Therapeutics Inc. (NASDAQ: RPRX), Nektar Therapeutics (NASDAQ: NKTR), Akorn Inc. (NASDAQ: AKRX), AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX), and Pernix Therapeutics Holdings Inc. (NASDAQ: PTX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, October 31, 2014, the NASDAQ Composite ended at 4,630.74, up 1.41%, the Dow Jones Industrial Average advanced 1.13%, to finish the day at 17,390.52, and the S&P 500 closed at 2,018.05, up 1.17%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 778.85, up 0.51%, with the index also advancing 10.60% in the previous three months. Register for your complimentary reports on these five stocks at:
ACRX: 5.63 (-0.58), PTX: 9.26 (-0.05), AKRX: 37.88 (-3.80), RPRX: 6.45 (+0.03), NKTR: 13.56 (-0.04)
IBD 50 Caps Impressive 2-Week Rally
at Investor's Business Daily - Fri Oct 31, 5:47PM CDT
The IBD 50 just capped its best two-week performance in more than three years -- a run that's produced a batch of breakouts. The index rallied 9.4% over the past two weeks. That's the best two-week period since July 2011, when the IBD 50 roared...
ODFL: 75.25 (+1.04), AAP: 145.56 (-3.81), AKRX: 37.88 (-3.80), ILMN: 189.87 (+3.50), NXPI: 73.47 (+0.11), CDW: 32.48 (+1.15), CELG: 107.14 (+1.99), BIDU: 236.90 (-0.80), GILD: 106.94 (+0.89), JAZZ: 172.37 (+5.19), FLT: 150.47 (+1.96), FL: 54.47 (+1.76), AAPL: 108.70 (-0.16), AVGO: 87.63 (+0.92)
Lannett Co. Gets Growth Rx In Generic Drugs Group
at Investor's Business Daily - Mon Oct 27, 4:59PM CDT
Generic-drug maker Lannett Co. boasts a robust pipeline and has its sights on growing revenue substantially over the next several years. The Philadelphia-based company is already on solid footing. In late August, it reported fiscal 2014...
LCI: 50.99 (-2.16), PRGO: 152.49 (-6.01), ACT: 250.38 (+2.47), AKRX: 37.88 (-3.80), TEVA: 58.72 (+0.93)
IBD 50 Stocks Regain Buy Points
at Investor's Business Daily - Fri Oct 24, 5:54PM CDT
The IBD 50 has been the land of the second chance, as many stocks have rebounded from sell signals. In several cases, stocks triggered the 8% sell rule or hit another sell signal. Yet a lot of them have rallied back and reclaimed their buy points....
AKRX: 37.88 (-3.80), ALXN: 193.14 (+3.25), CELG: 107.14 (+1.99)
(0)
(0)Akorn Inc. (AKRXQ) Stock Research Links
Scroll down for more posts ▼